Global Usage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Will QR codes improve access to food labels? | Explained

Will QR codes improve access to food labels? | Explained
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Ashim sanyalPrakash beraStandards authority of indiaWorld health organizationGlobal health advocacy incubatorFood safetyStandards authorityWorld healthDisabilities actDenso waveFood productLatest numbersGlobal usage

Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients

Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaKim hannaClinical developmentInvestors relations department sustainabilityDrug administrationMarketing research bureauMedia press officetelSpanish stock exchangeUnited states foodGrifols senior director clinicalImmune globulinChromatography purifiedPrescribing informationNorth americaMiddle east

Grifols Achieves Positive Topline Results From Phase 4

Clinical trial met primary endpoint demonstrating comparable total immunoglobulin (Ig) levels when administering XEMBIFY® (Grifols’ subcutaneous Ig) every.

United statesComunidad autonoma de catalunaKim hannaMarketing research bureauSpanish stock exchangeClinical developmentDrug administrationInvestors relations department sustainabilityMedia press officeUnited states foodGrifols senior director clinicalImmune globulinChromatography purifiedPrescribing informationNorth americaMiddle east

People are already bored of Meta s Twitter rival Threads as daily usage drops by 50 per cent in just 10 days

Threads, the fast-growing app that gained over 150 million downloads in just 10 days, is facing a drop in daily usage by almost 50 percent, with users now spending only 10 minutes per day on the platform. Despite this setback, Meta plans to introduce more features similar to Twitter in hopes of increasing usage and improving the user experience, while India leads in app downloads followed by Brazil and the United States.

United statesElon muskAnkita chakravartiSensor towerDaily useSensor towerAndroid phonesStable performanceUser experienceData aiUnited statesElon muskGlobal usageAd revenueProfile page viewsFinancial challenges

Grifols begins European launch of XEMBIFY in Spain to treat immunodeficiencies

Barcelona, Spain - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global leader in plasma medicines, has started marketing XEMBIFY®, its 20% subcutaneous immunoglobulin, in Spain. This plasma medicine is indicated for treating primary immunodeficiencie.

United kingdomComunidad autonoma de catalunaUnited statesGuillain barreJoana sabatWa carrock sewellResearch bureauEuropean unionHematology groupSenior vice presidentBiopharma launchExpanding fieldSecondary antibody deficiencyPractice guidelinesReport analysisGlobal usage